首页> 美国卫生研究院文献>Clinical Molecular Pathology >Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients
【2h】

Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients

机译:一组马来西亚患者的浸润性宫颈癌中端粒酶活化和人乳头瘤病毒感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Aim: Telomerase activity was studied in invasive uterine cervical carcinoma to assess whether it was activated during cervical malignant transformation and to look for a possible association with human papillomavirus (HPV) infection in a set of Malaysian patients.Methods: Histologically confirmed invasive cervical carcinoma and benign cervices were assayed for telomerase activity using a commercial telomerase polymerase chain reaction (PCR) enzyme linked immunosorbent assay kit. The same cases were subjected to PCR detection of HPV using type specific (HPV types 6b, 11, 16, and 18) followed by L1 open reading frame (ORF) consensus primers.Results: HPV was detected in 18 (13 HPV-16, one HPV-6b, four only L1 ORF) of 20 invasive cervical carcinoma and one (only L1 ORF) of 19 benign cervices. Raised telomerase activity (A450 nm > 0.215) was detected in 11 cervical carcinomas, with A450 nm ranging between 0.238 and 21.790 (mean, 3.952) in positive squamous carcinomas, whereas A450 nm was only 0.222 in the one positive adenosquamous carcinoma. Five of 11 cervical carcinomas in stage I, three of six in stage II, both in stage III, and the only case in stage IV showed telomerase activation. Increased telomerase activity was noted in five of the 12 lymph node negative, five of the seven lymph node status unknown cases, and the one case with presumed lymph node metastasis. Ten of 18 HPV positive and one of two HPV negative cervical carcinomas showed telomerase upregulation.Conclusions: Telomerase is activated in invasive cervical carcinoma. Although larger studies are needed, there seems to be no clear association between telomerase upregulation and HPV status, although there is a suggestion of increased telomerase activity in squamous carcinomas and late stage disease.
机译:目的:在宫颈浸润性宫颈癌中研究端粒酶活性,以评估其是否在宫颈恶性转化过程中被激活,并寻找一组马来西亚患者与人乳头瘤病毒(HPV)感染的可能关系。使用市售的端粒酶聚合酶链反应(PCR)酶联免疫吸附测定试剂盒,检测良性宫颈癌的端粒酶活性。对同一病例进行HPV PCR检测(使用HPV 6b,11、16和18型),然后使用L1开放阅读框(ORF)共有引物。结果:在18株HPV-16(13 HPV-16, 1例HPV-6b,20例浸润性宫颈癌中只有4例L1 ORF)和19例良性宫颈癌中只有1例L1 ORF。在11例子宫颈癌中检测到端粒酶活性升高(A450 nm> 0.215),在阳性鳞状鳞癌中A450 nm介于0.238和21.790(平均值,3.952)之间,而在一个阳性鳞状鳞癌中A450 nm仅0.222。 I期的11种宫颈癌中有5种,II期的6种中的3种,均在III期,IV期的唯一病例显示端粒酶活化。在12例淋巴结阴性的患者中有5例,在7例淋巴结状态未知的患者中有5例和1例有淋巴结转移的患者中发现端粒酶活性增加。 18例HPV阳性的宫颈癌中有10例和2例HPV阴性的宫颈癌之一表现出端粒酶上调。结论:端粒酶在浸润性宫颈癌中被激活。尽管需要进行更大的研究,但端粒酶上调与HPV状况之间似乎没有明确的关联,尽管有人认为鳞状癌和晚期疾病的端粒酶活性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号